Entera Bio Ltd. (ENTX)
NASDAQ: ENTX
· Real-Time Price · USD
1.99
0.02 (1.02%)
At close: Aug 15, 2025, 3:59 PM
2.00
0.50%
After-hours: Aug 15, 2025, 07:57 PM EDT
Entera Bio Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 12.57M | 8.66M | 6.92M | 9.13M | 9.26M | 11.02M | 7.58M | 9.13M | 10.69M | 12.31M | 14.32M | 17.28M | 20.11M | 24.89M | 27.39M | 26.93M | 16.38M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 98K | 86K | 6K | 6K | 6K | 6K | 6K | 6K | 54K | 6K | 6K | 46K | 46K | 46K | n/a | n/a | n/a |
Receivables | 126K | 126K | 42K | 126K | n/a | n/a | n/a | 29K | 29K | 246K | 233K | 225K | 210K | 183K | 252K | 116K | 15K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 296K | -653K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 8.16M | 186K | 167K | 67K | 109K | 238K | 263K | 354K | 653K | 294K | 634K | 922K | 1.32M | 254K | 459K | 863K | 1.04M |
Total Current Assets | 21.22M | 8.97M | 7.34M | 9.6M | 9.75M | 11.26M | 8.02M | 9.81M | 11.37M | 12.85M | 15.19M | 18.43M | 21.64M | 25.33M | 28.11M | 27.91M | 17.43M |
Property-Plant & Equipment | 284K | 332K | 381K | 420K | 468K | 488K | 528K | 582K | 136K | 229K | 278K | 336K | 375K | 395K | 405K | 429K | 488K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 605K | 605K | 605K |
Total Long-Term Assets | 382K | 418K | 401K | 440K | 488K | 508K | 549K | 631K | 233K | 278K | 350K | 662K | 671K | 658K | 1.01M | 1.03M | 1.09M |
Total Assets | 21.6M | 9.39M | 7.74M | 10.04M | 10.24M | 11.77M | 8.56M | 10.45M | 11.61M | 13.13M | 15.54M | 19.09M | 22.31M | 25.99M | 29.12M | 28.94M | 18.53M |
Account Payables | 134K | 132K | 184K | 69K | 66K | 83K | 564K | 240K | 150K | 17K | 413K | 109K | 199K | 166K | 325K | 289K | 440K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 43K | n/a | -172K | n/a | 15K | 1.69M | 8K | 15K |
Short-Term Debt | n/a | n/a | n/a | n/a | 153K | 134K | n/a | 140K | 48K | 91K | 129K | 172K | n/a | 179K | n/a | n/a | n/a |
Other Current Liabilities | 384K | 339K | 428K | 644K | 318K | 366K | 980K | 982K | 903K | 842K | 249K | 777K | 1.47M | 2.03M | 2.39M | 2.87M | 9.98M |
Total Current Liabilities | 1.62M | 1.18M | 1.11M | 1.29M | 1.12M | 1.09M | 2.03M | 1.86M | 1.49M | 1.34M | 1.19M | 1.69M | 2.33M | 3.16M | 2.89M | 3.35M | 10.62M |
Long-Term Debt | n/a | n/a | n/a | n/a | 224K | 256K | n/a | 316K | n/a | n/a | 3K | 5K | 98K | 123K | n/a | n/a | n/a |
Other Long-Term Liabilities | 547K | 32K | 31K | 30K | -193K | -224K | 31K | -284K | 32K | 32K | 29K | 117K | 37K | 15K | 88K | 88K | 78K |
Total Long-Term Liabilities | 598K | 134K | 178K | 209K | 255K | 288K | 302K | 348K | 32K | 32K | 35K | 127K | 233K | 261K | 241K | 275K | 298K |
Total Liabilities | 2.22M | 1.31M | 1.29M | 1.5M | 1.38M | 1.38M | 2.33M | 2.21M | 1.53M | 1.37M | 1.23M | 1.82M | 2.57M | 3.42M | 3.13M | 3.62M | 10.91M |
Total Debt | 220K | 272K | 309K | 334K | 377K | 390K | 402K | 456K | 48K | 91K | 132K | 177K | 240K | 302K | 332K | 371K | 402K |
Common Stock | 1K | 1K | 1K | 1K | 1K | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Retained Earnings | -116.49M | -113.93M | -111.57M | -108.55M | -106.4M | -104.39M | -102.39M | -100.01M | -97.69M | -95.5M | -92.46M | -89.39M | -86.21M | -82.43M | -90M | -87.54M | -82.38M |
Comprehensive Income | 41K | 41K | 41K | 41K | 41K | 41K | 41K | 41K | 41K | 41K | 41K | 41K | 41K | 41K | 10.18M | 9.76M | 9.17M |
Shareholders Equity | 19.38M | 8.08M | 6.45M | 8.53M | 8.86M | 10.39M | 6.24M | 8.23M | 10.08M | 11.75M | 14.31M | 17.27M | 19.75M | 22.57M | 25.98M | 25.32M | 7.61M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |